Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for POCD After Cardiac Surgery
NCT03480061Phase 4Active, not recruiting
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Aug 2018
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in Post-operative cognitive dysfunction (POCD), delirium, sponsored by Sunnybrook Health Sciences Centre. Started Aug 2018; status: active, not recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Post-operative cognitive dysfunction (POCD)delirium
Beyond the preview
Go deeper on NCT03480061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03480061.